449
Participants
Start Date
November 10, 2015
Primary Completion Date
July 31, 2019
Study Completion Date
December 31, 2019
Rifaximin
Rifaximin will be provided to subjects either daily with placebo, or twice daily depending on which of the two experimental arms they are randomized to
Placebo
Placebo will be administered twice daily or once daily with rifaximin depending on which experimental arm they are randomized to
Naval Hospital Camp Lejeune, Marine Corps Base Camp Lejeune
San Antonio Military Medical Center, San Antonio
Naval Medical Center San Diego, San Diego
Tripler Army Medical Center/Schofield Barracks, Honolulu
Madigan Army Medical Center, Tacoma
British Army Training Unit Kenya, Nanyuki
Collaborators (1)
Naval Medical Research Center
FED
Ministry of Defence, United Kingdom
OTHER_GOV
Henry M. Jackson Foundation for the Advancement of Military Medicine
OTHER